Page last updated: 2024-11-05

tranexamic acid and Adenocarcinoma, Mucinous

tranexamic acid has been researched along with Adenocarcinoma, Mucinous in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Adenocarcinoma, Mucinous: An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"In the present phase II trial, 26 heavily pretreated patients with advanced recurrent ovarian carcinoma were treated with tranexamic acid, 4-6 g per os daily for at least 3 months."7.66Tranexamic acid for the treatment of advanced ovarian carcinoma. ( Johnsson, JE; Sigurdsson, K; Tropé, C, 1983)
"In the present phase II trial, 26 heavily pretreated patients with advanced recurrent ovarian carcinoma were treated with tranexamic acid, 4-6 g per os daily for at least 3 months."3.66Tranexamic acid for the treatment of advanced ovarian carcinoma. ( Johnsson, JE; Sigurdsson, K; Tropé, C, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sigurdsson, K1
Johnsson, JE1
Tropé, C1

Other Studies

1 other study available for tranexamic acid and Adenocarcinoma, Mucinous

ArticleYear
Tranexamic acid for the treatment of advanced ovarian carcinoma.
    Acta obstetricia et gynecologica Scandinavica, 1983, Volume: 62, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Carcinoma; Cyclohexanecarboxylic Acids; Drug

1983